Punjab’s New Drug Worry: Study Flags Misuse of Pregabalin

A recent epidemiological investigation conducted under the auspices of the Punjab State Health Department has disclosed a troubling escalation in the non‑therapeutic consumption of the neuropathic analgesic pregabalin across several densely populated municipal districts, notably within the urban agglomerations of Ludhiana, Amritsar, and Jalandhar. The study, which employed a stratified sampling methodology encompassing both licensed pharmacy dispensation records and anonymised patient‑reported usage surveys, revealed that approximately fourteen percent of respondents admitted to obtaining the substance without a bona‑fide prescription, thereby contravening statutory provisions established under the Drugs and Cosmetics Act of 1940 as subsequently amended. Municipal health officers, tasked with the oversight of pharmaceutical compliance within their respective jurisdictional boundaries, have hitherto demonstrated a conspicuous reluctance to enforce existing inspection schedules, a shortcoming repeatedly cited in internal audit reports yet ostensibly dismissed as a mere procedural inconvenience by senior administrative officials.

In response to public outcry manifested through petitions submitted to the district magistrates and local elected representatives, the Punjab Police Department initiated a limited series of raids upon suspected wholesale distributors, yet the resultant seizures amounted to a fraction of the estimated market volume, thereby underscoring the inadequacy of a reactive enforcement paradigm predicated upon episodic interdiction rather than sustained regulatory vigilance. Compounding the predicament, the State Pharmacy Council, whose statutory remit includes the accreditation of dispensing establishments and the promulgation of continuing‑education requirements for pharmacists, has yet to promulgate any updated guidelines addressing the emergent risk of off‑label pregabalin diversion, a lapse that has been repeatedly highlighted in recent minutes of council deliberations yet remains unaddressed amidst competing budgetary considerations. Consequently, ordinary citizens residing in these metropolitan precincts report heightened anxiety regarding inadvertent exposure to psychoactive substances, a phenomenon documented by local primary‑care physicians who note an increase in emergency‑room presentations for agitation, insomnia, and unexplained syncope subsequent to unsupervised ingestion of the medication in question. Public health advocates, invoking the principle of precaution embedded within the constitutionally enshrined right to health, have petitioned the High Court for an interlocutory injunction mandating the immediate suspension of all non‑essential pregabalin dispensing pending a comprehensive risk‑assessment study, a request that presently lies pending before a bench whose jurisprudential leanings remain to be ascertained.

Should the municipal health oversight apparatus, whose statutory obligations expressly include the regular auditing of pharmacy compliance and the enforcement of licencing conditions, be deemed constitutionally liable for the foreseeable public health hazards engendered by its documented inaction in curbing the illicit procurement of pregabalin within densely inhabited urban quarters? May the Punjab Police, under the aegis of the state’s criminal procedure code and endowed with the duty to prevent the distribution of scheduled medicines, be held accountable for the apparent insufficiency of its intermittent raid strategy that fails to proportionally reflect the scale of the market penetration revealed by the recent health department study? Is it not incumbent upon the State Pharmacy Council, whose regulatory charter mandates the periodic revision of dispensing guidelines and the imposition of punitive measures upon non‑compliant entities, to institute an expedited protocol for monitoring pregabalin sales, thereby furnishing empirical evidence that might substantiate or invalidate the allegations of widespread misuse currently circulating within the public sphere?

Could the allocation of municipal budgetary resources, presently directed toward infrastructural projects such as roadway expansion and commercial zoning, be deemed misaligned with the urgent need for augmented funding of drug‑monitoring units and community education campaigns, thereby contravening the principle of equitable distribution of public services as articulated in the state's fiscal policy framework? Might the procedural safeguards embedded within the Punjab State Grievance Redressal Mechanism, which purports to provide expeditious remedies for citizens reporting pharmaceutical irregularities, be considered ineffective given the documented delays and paucity of transparent feedback experienced by complainants seeking assistance in curbing the illicit flow of pregabalin? Does the prevailing legal doctrine governing administrative discretion, which permits regulatory bodies to exercise judgment in the prioritisation of enforcement actions, sufficiently protect the public interest when empirical evidence suggests a systemic undervaluation of drug‑misuse threats relative to more visible civic concerns such as traffic management and sanitation? Will future legislative amendments be proposed to tighten the definition of a 'essential' prescription for pregabalin, thereby obligating clinicians to substantiate medical necessity with documented diagnostic criteria before issuing the controlled substance?

Published: May 11, 2026